SMD marketing company edited annual pharmaceutical market survey «Ukraine in prospect - 2014» and the experts form Legal Alliance Company became the co-authors of the legal part of this survey.
The analytical part of the survey includes the country profile (geography, democracy and political state), data on its economic development (key economic figures), review of healthcare system peculiarities (structure, state programs) and the Ukrainian pharmaceutical market profile, including top ATC categories, dynamic of Rx / OTC segments, average package cost, leading corporations / products / MHH, prospects of market development for 3 years.
The legal part includes the analysis of regulatory changes on Ukrainian pharmaceutical market in 2014 and prospect of further development. “We can talk about numerous legislative initiatives concerning pharmaceutical sector in 2014, essential amendments currently and in future. The permanent unsteadiness influences negatively market state as well as the reduction of market and economy. We still believe in European future of Ukraine and are working on adaptation of Ukrainian legislation to European standards.” – Dmytro Aleshko, Partner at Legal Alliance Company, said about prospects.
Ukraine in prospect, published by SMD for several years, is popular mostly among companies aiming to enter into regional pharmaceutical market, which is always connected with challenges and risks concerning political, financial and economic state.
Except Ukrainian market, SMD reviews pharmaceutical markets of East Europe countries, Caucasus and Central Asia, containing the relevant data on risks and opportunities of each market for successful development of pharmaceutical market.
The survey is now available. We are glad to inform that clients of Legal Alliance Company can buy the survey with exclusive discount of 20%.
In you are interested in buying of the survey with discount, please, contact with managers of marketing department of Legal Alliance Company by tel.: +38 (044) 425-40-50 or by e-mail pr@l-a.com.ua.
The event focused on the transformation of Ukraine's intellectual property sector on its path toward European integration.
Improving access to safe and affordable medicines for the Ukrainian population is one of the Government of Ukraine's top priorities. SAFEMed Activity (2017-2025) has supported this effort by appIying health system strengthening best practices.
The Ministry of Health website has posted a notice about the release of a revised draft order of the Ministry of Health ‘On Approval of Amendments to Certain Re
On 25 September, a webinar was held on the topic: ‘180 days of new drug price regulation. Results, prospects and practical advice.’ The event was organized by LA Law Firm in partnership with Proxima Research International.
